[go: up one dir, main page]

MA23953A1 - NEW PROCESS FOR FORMULATING SOLID DOSAGE FORMS, AND DOSAGE FORMS THUS PRODUCED - Google Patents

NEW PROCESS FOR FORMULATING SOLID DOSAGE FORMS, AND DOSAGE FORMS THUS PRODUCED

Info

Publication number
MA23953A1
MA23953A1 MA24329A MA24329A MA23953A1 MA 23953 A1 MA23953 A1 MA 23953A1 MA 24329 A MA24329 A MA 24329A MA 24329 A MA24329 A MA 24329A MA 23953 A1 MA23953 A1 MA 23953A1
Authority
MA
Morocco
Prior art keywords
dosage forms
produced
new process
formulating solid
solid dosage
Prior art date
Application number
MA24329A
Other languages
French (fr)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA23953A1 publication Critical patent/MA23953A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA24329A 1995-07-29 1996-07-26 NEW PROCESS FOR FORMULATING SOLID DOSAGE FORMS, AND DOSAGE FORMS THUS PRODUCED MA23953A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process

Publications (1)

Publication Number Publication Date
MA23953A1 true MA23953A1 (en) 1997-04-01

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24329A MA23953A1 (en) 1995-07-29 1996-07-26 NEW PROCESS FOR FORMULATING SOLID DOSAGE FORMS, AND DOSAGE FORMS THUS PRODUCED

Country Status (25)

Country Link
EP (1) EP0841902A2 (en)
JP (1) JPH11510493A (en)
KR (1) KR19990035972A (en)
CN (1) CN1196677A (en)
AP (1) AP858A (en)
AR (1) AR004178A1 (en)
AU (1) AU716961B2 (en)
BG (1) BG102266A (en)
BR (1) BR9609804A (en)
CA (1) CA2228048A1 (en)
CZ (1) CZ24798A3 (en)
DZ (1) DZ2077A1 (en)
EA (2) EA199901055A1 (en)
HU (1) HUP9900521A3 (en)
IL (1) IL122897A0 (en)
MA (1) MA23953A1 (en)
MX (1) MX9800809A (en)
NO (1) NO980384L (en)
NZ (1) NZ315632A (en)
OA (1) OA10659A (en)
PL (1) PL325242A1 (en)
SK (1) SK11098A3 (en)
TR (1) TR199800156T1 (en)
UY (1) UY24297A1 (en)
WO (1) WO1997004750A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
KR20010034588A (en) * 1998-03-11 2001-04-25 피터 기딩스 Composition
FR2796840B1 (en) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques LOW-DOSE TABLETS AND METHOD OF PREPARATION
CZ306435B6 (en) 2000-12-14 2017-01-25 Ortho-Mcneil Pharmaceutical, Inc. A steroid hormone product and the method of its preparation
US20070202179A1 (en) * 2004-04-09 2007-08-30 FAULKNER Patrick Low Dose Pharmaceutical Products
WO2026018155A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists
WO2026018154A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with non-cns penetrant muscarinic antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (en) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd Wet solid pharmaceutical preparation of very small amount of main drug
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
DE69034146T2 (en) * 1989-04-13 2005-07-14 Beecham Group P.L.C., Brentford Chemical compounds
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
NZ315632A (en) 1999-11-29
NO980384D0 (en) 1998-01-28
AR004178A1 (en) 1998-11-04
MX9800809A (en) 1998-04-30
EA199901055A1 (en) 2000-06-26
CZ24798A3 (en) 1998-06-17
EP0841902A2 (en) 1998-05-20
DZ2077A1 (en) 2002-07-22
BR9609804A (en) 1999-07-06
AP9801170A0 (en) 1998-01-31
JPH11510493A (en) 1999-09-14
PL325242A1 (en) 1998-07-06
UY24297A1 (en) 1997-01-23
SK11098A3 (en) 1998-07-08
EA199800179A1 (en) 1998-10-29
CN1196677A (en) 1998-10-21
KR19990035972A (en) 1999-05-25
TR199800156T1 (en) 1998-04-21
CA2228048A1 (en) 1997-02-13
AU6738496A (en) 1997-02-26
NO980384L (en) 1998-03-26
EA000740B1 (en) 2000-02-28
WO1997004750A3 (en) 1997-03-27
HUP9900521A2 (en) 1999-06-28
HUP9900521A3 (en) 2001-04-28
WO1997004750A2 (en) 1997-02-13
OA10659A (en) 2002-09-18
AU716961B2 (en) 2000-03-09
AP858A (en) 2000-07-12
BG102266A (en) 1998-10-30
IL122897A0 (en) 1998-08-16

Similar Documents

Publication Publication Date Title
MA26410A1 (en) PHARMACEUTICAL FORMULATIONS AND PROCESS FOR THEIR PRODUCTION.
EP0723469A4 (en) CURVILINATED ELECTRODE AND METHOD FOR FORMING LESIONS
FR2685916B1 (en) MIXED NO SYNTHASE AND CYCLOOXYGENASE INHIBITORS AND A PROCESS FOR THEIR PREPARATION.
MA26508A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE, AND PROCESS FOR THEIR PREPARATION.
MA23528A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS
MA22521A1 (en) ANTI-BREATHING COMPOSITIONS IN GEL-STICKS CONTAINING 2-OXAZOLIDINONE DERIVATIVE, AND PROCESS FOR THEIR PREPARATION
FR10C0011I2 (en) BENZAMIDOXIME DERIVATIVE, PRODUCTION PROCESS, AND AGROORTICAL BACTERICIDE
MA23395A1 (en) PROCESS FOR THE PREPARATION OF NEW FORMULATIONS
MA23942A1 (en) NOVEL FORMULATION CONTAINING PAROXETINE, AND PROCESS FOR ITS PREPARATION
FR2780728B1 (en) NEW PAROXETINE SALT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2772617B1 (en) PROGESTERONE TABLET AND PROCESS FOR THE PREPARATION THEREOF
FR2739860B1 (en) AMPHIPHILIC COMPLEXES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THE SAME
MA25418A1 (en) PROCESS FOR PRODUCING RAPIDLY DECOMPOSABLE SOLID PHARMACEUTICAL PREPARATIONS.
FR2722210B1 (en) NOVEL STREPTOGRAMINS AND PROCESS FOR THE PREPARATION OF STREPTOGRAMINS BY MUTASYNTHESIS
FR2729653B1 (en) IMPROVED DEPHOSPHATATION PROCESS FOR WASTEWATER
EP0763097A4 (en) PROCESS FOR THE PREPARATION OF TETRAHYDROISOALPHA ACIDS
MA23953A1 (en) NEW PROCESS FOR FORMULATING SOLID DOSAGE FORMS, AND DOSAGE FORMS THUS PRODUCED
MA26708A1 (en) NEW INDOLE DERIVATIVE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA24183A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS BASED ON DICLOFENAC
MA22866A1 (en) PROCESS FOR THE PREPARATION OF COMPOUNDS FOR THE TREATMENT OF NEURO-DEGENERATIVE DISORDERS.
FR2700956B1 (en) COSMETIC AND PHARMACEUTICAL COMPOSITION AND PROCESS FOR ITS PREPARATION.
MA24346A1 (en) PROCESS FOR THE PREPARATION OF ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS
FR2727314B1 (en) PROCESS FOR THE PERMANENT DEFORMATION OF KERATINIC MATERIALS
MA24586A1 (en) DOSAGE FORMS OF SERTRALINE AND PROCESS FOR THEIR PREPARATION.
EP0823904A4 (en) PROCESS FOR THE PREPARATION OF SPIROINDOLINES